Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Itraconazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 80Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AstraZeneca cans ph. 2 OUD drug over antifungal interaction
    AstraZeneca cans ph. 2 OUD drug over antifungal interaction

    23 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astrazeneca-cans-phase-2-opioid-use-disorder-drug-over-interaction-antifungal

    FIERCE BIOTECH
    23 Nov 2024
    Share Share
    Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan
    Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan

    22 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/22/2934230/0/en/Inhibitor-Therapeutics-Inc-Provides-Update-on-its-Clinical-Development-Plan.html

    GLOBENEWSWIRE
    22 Aug 2024
    Share Share
    Pulmatrix Announces Publication on PUR1900, Orally Inhaled Itraconazole
    Pulmatrix Announces Publication on PUR1900, Orally Inhaled Itraconazole

    23 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pulmatrix-announces-publication-on-physiologically-based-pharmacokinetic-modelling-of-potential-drug-drug-interactions-with-pur1900-orally-inhaled-itraconazole-301907549.html

    PR NEWSWIRE
    23 Aug 2023
    Share Share
    Indian firm Intas Pharma makes breakthrough in antifungal therapy domain
    Indian firm Intas Pharma makes breakthrough in antifungal therapy domain

    13 Oct 2021

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/19206/indian-firm-intas-pharma-makes-breakthrough-in-antifungal-therapy-domain.html

    BIOSPECTRUMASIA
    13 Oct 2021
    Share Share
    Gannex Positive Topline Results from the U.S. Phase I Trial of ASC41
    Gannex Positive Topline Results from the U.S. Phase I Trial of ASC41

    07 Sep 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/gannex-announces-positive-topline-results-from-the-u-s-phase-i-trial-of-drug-drug-interactions-in-healthy-subjects-and-pharmacokinetics-in-patients-with-nafld-for-its-thr%ce%b2-agonist-asc41/

    BIOSPACE
    07 Sep 2021
    Share Share
    Enforcement Report - Week of April 21, 2021
    Enforcement Report - Week of April 21, 2021

    22 Apr 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-21-2021-1619072775.pdf

    FDA
    22 Apr 2021
    Share Share